Brief ReportPap Test Use Is Lower Among Female-to-Male Patients Than Non-Transgender Women
Introduction
Scant research has addressed cervical cancer screening in female-to-male (FTM) transgender men. Transgender men are individuals assigned a female sex at birth who identify as men, transmen, or along a transmasculine spectrum; the majority retain a cervix and should undergo Pap testing. FTM individuals are often marginalized, lack access to health care, and may have unique barriers to receiving gynecologic examinations despite a higher prevalence of certain cervical cancer risk factors, such as smoking and sexual violence.1, 2 Understanding Pap utilization among transgender men is important.3 This study describes the prevalence of Pap test utilization among FTM compared to non-transgender female patients and examines predictors of adherence to Pap testing at Fenway Health (FH), an urban primary healthcare clinic in Boston MA that serves a large lesbian, gay, bisexual, and transgender (LGBT) patient population.4
Section snippets
Methods
This study was an observational retrospective chart review. Data were extracted from the electronic medical record (EMR) via electronic query and manual review of patient charts at FH in 2013. All HIV-negative primary care patients aged 21–64 years (inclusive) with a medical visit in 2012 and who had a cervix as of December 31, 2012, were included in the study. HIV-positive patients were excluded, as they follow different screening guidelines. The study was approved by the FH IRB.
Results
A total of 5,232 patients were included. Overall, 3,815 of patients (72.9%) were up-to-date with Pap testing (Table 2), and 3,590 (73.5%) female patients and 225 (64.3%) FTM patients were up-to-date. FTM patients had a 37% lower odds of being up-to-date compared to non-transgender female patients after adjustment for other variables. Additional factors negatively associated with being up-to-date were never having had sex or unknown sexual history (compared to sex exclusively with men); student
Discussion
The proportion of FTM patients who were up-to-date was 9.2 percentage points lower compared to non-transgender female patients, and being transgender was an independent predictor associated with a 37% lower odds of being up-to-date. Even at a clinic where providers have expertise caring for LGBT populations,4 transgender patients are not achieving screening rates equivalent to non-transgender women. There is a need to better understand barriers to care in this patient population.12, 13, 14
In
Acknowledgments
There are no conflicts of interest to declare. This work was funded through the FY 2012 Supplemental Funding for Quality Improvement in Health Centers grant (No. H80CS00303) provided by the Health Resources and Services Administration at the U.S. Department of Health and Human Services.
No financial disclosures were reported by the authors of this paper.
References (30)
- et al.
Gynecologic care of the female-to-male transgender man
J Midwifery Womens Health
(2008) - et al.
Managing uncertainty: a grounded theory of stigma in transgender health care encounters
Soc Sci Med
(2013) - et al.
Correlates of underutilization of gynecological cancer screening among lesbian and heterosexual women
Prev Med
(2004) - et al.
Reproductive health screening disparities and sexual orientation in a cohort study of U.S. adolescent and young adult females
J Adolesc Health
(2011) - et al.
At the intersection of sexual orientation, race/ethnicity, and cervical cancer screening: Assessing Pap test use disparities by sex of sexual partners among black, Latina, and white U.S. women
Soc Sci Med
(2014) - et al.
Smoking and cancer screening for women ages 42 -75: associations in the 1990 -1994 National Health Interview Surveys
Prev Med
(1999) - et al.
Transgender health in Massachusetts: results from a household probability sample of adults
Am J Public Health
(2012) - et al.
Injustice at every turn: a report of the National Transgender Discrimination Survey
(2011) - et al.
Fenway Community Health’s model of integrated, community-based LGBT care, education, and research
- Screening for Cervical Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation. AHRQ Publication...
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
CA Cancer J Clin
2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests
J Low Genit Tract Dis
Multilevel modeling and practice-based research
Ann Fam Med
Multilevel analysis: an introduction to basic and advanced multilevel modeling
Multilevel analysis: techniques and applications
Cited by (139)
Challenges of Gender-Affirming Care in Incarcerated Transgender People
2023, Endocrinology and Metabolism Clinics of North AmericaEffects of trauma history on cancer-related screening, diagnosis, and treatment
2023, The Lancet OncologyCancer Screening for Transgender Individuals: Guidelines, Best Practices, and a Proposed Care Model
2023, Urologic Clinics of North AmericaGender-affirming hormonal therapy for transgender and gender-diverse people—A narrative review
2023, Best Practice and Research: Clinical Obstetrics and GynaecologyCitation Excerpt :The HPV prevalence in self-collected vaginal swabs of transmasculine people (16%) also appears comparable to the prevalence in cisgender women [127]. The risk of cervical cancer may be higher in transmasculine people because of a lower number of people accessing screening programs [128]. In addition, testosterone therapy may lead to tissue epithelial atrophy and shrinkage in the genital tract, which may cause discomfort and pain upon speculum insertion and cervical screening [129].
Sexual and Gender Minority Patients’ First Pelvic Examination Experiences: What Clinicians Need to Know
2023, Journal of Pediatric and Adolescent Gynecology